BSD Medical Sells Two BSD-2000 Hyperthermia Systems to Chinese Distributor

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today the sale of two BSD-2000 hyperthermia systems to Dalian Orientech Co. LTD (“Dalian Orientech”), the Company’s exclusive Chinese distributor. The BSD-2000 system non-invasively delivers localized therapeutic heating (hyperthermia) by applying radiofrequency (RF) energy to certain cancerous tumors, including those located deep within the body. Clinical studies have shown that hyperthermia treatment can kill cancer cells directly as well as increase the effectiveness of other cancer therapies, including radiation therapy and chemotherapy, for the treatment of certain tumors.

MORE ON THIS TOPIC